PMGC Holdings (ELAB) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$2.6M

Revenue (quarter)

$1.3M

Revenue growth (year over year)

—

Gross profit (trailing twelve months)

$801,479.00

Gross margin

31.08%

Net income (trailing twelve months)

−$13.5M

Net income (quarter)

−$2.9M

Net income growth (year over year)

−423.05%

Net margin

−522.97%

Return on equity

−104.60%

EPS (trailing twelve months)

−$206.80

Book value per share

$27.20

P/E (trailing twelve months)

—

Price to book

0.15

Debt to assets

54.23%

Payout ratio

—

Dividend yield

—

Company profile

PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

• Is PMGC Holdings (ELAB) profitable?

  No. PMGC Holdings reported a net loss of $13.5M over the trailing twelve months.

• How much revenue does PMGC Holdings (ELAB) make?

  PMGC Holdings generated $2.6M in revenue over the trailing twelve months.

• How do I buy stock in PMGC Holdings (ELAB)?

  ELAB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.